Statistics about Health, Pharma & Medtech in United States
Statistics
- Histogen net cash 2018-2022
- Protokinetix total assets 2019-2023
- Protalix Biotherapeutics total assets 2019-2023
- Sigilon Therapeutics total assets 2020-2022
- Global Blood Therapeutics, Inc. total assets 2017-2021
- Progyny total equity 2019-2023
- Pure Harvest Corporate Group total equity 2016-2020
- Greater Cannabis Company gross profit 2017-2021
- Harmony Biosciences Holdings total equity 2019-2023
- Poseida Therapeutics net income 2019-2023
- Shuttle Pharmaceuticals Holdin total equity 2020-2023
- Sigilon Therapeutics total equity 2019-2022
- Seagen Inc. total equity 2018-2022
- Prelude Therapeutics net income 2019-2023
- American Clean Resources Group total equity 2019-2023
- Humacyte, Inc. total equity 2019-2023
- Histogen total equity 2018-2022
- Protalix Biotherapeutics total equity 2019-2023
- Genprex, Inc net income 2017-2018
- Protokinetix total equity 2019-2023
- Humacyte, Inc. total assets 2020-2023
- Silo Pharma, Inc. total assets 2019-2023
- Genprex, Inc total assets 2019-2023
- Histogen total assets 2018-2022
- Fulcrum Therapeutics liabilities 2019-2023
- Harmony Biosciences Holdings total assets 2019-2023
- Genprex, Inc net cash 2019-2023
- Genprex, Inc total equity 2019-2023
- Greater Cannabis Company net cash 2019-2023
- Greater Cannabis Company operating profit 2019-2023
- Provention Bio, Inc. net income 2018-2021
- Hillevax total equity 2020-2023
- Protokinetix liabilities 2016-2020
- Pure Harvest Corporate Group liabilities 2017-2020
- Shuttle Pharmaceuticals Holdin net cash 2021-2023
- Progyny liabilities 2019-2023
- Histogen net income 2018-2022
- Harmony Biosciences Holdings net income 2019-2023
- Hoth Therapeutics total equity 2019-2023
- Sigilon Therapeutics net cash 2020-2022
- Protalix Biotherapeutics operating profit 2019-2023
- Harmony Biosciences Holdings revenue 2019-2023
- Pure Harvest Corporate Group operating profit 2018-2020
- Progyny operating profit 2019-2023
- Seagen Inc. net cash 2018-2022
- Hepion Pharmaceuticals, Inc. total equity 2019-2023
- Protokinetix operating profit 2010-2012
- Hero Technologies total equity 2015-2022
- Hoth Therapeutics total assets 2019-2023
- Protalix Biotherapeutics gross profit 2013-2017
- American Clean Resources Group net cash 2019-2023
- Histogen revenue 2018-2022
- Protalix Biotherapeutics liabilities 2019-2023
- Global Blood Therapeutics, Inc. net cash 2017-2021
- Global Blood Therapeutics, Inc. total equity 2017-2021
- Global Blood Therapeutics, Inc. liabilities 2017-2021
- Global Blood Therapeutics, Inc. revenue 2019-2021
- Humacyte, Inc. liabilities 2020-2023
- Seagen Inc. total assets 2018-2022
- Global Blood Therapeutics, Inc. operating profit 2017-2021
- Histogen liabilities 2019-2022
- Progyny total assets 2019-2023
- Pure Harvest Corporate Group total assets 2016-2020
- Harmony Biosciences Holdings liabilities 2019-2023
- Silo Pharma, Inc. net cash 2019-2023
- Protalix Biotherapeutics net cash 2019-2023
- Histogen operating profit 2018-2022
- Harmony Biosciences Holdings operating profit 2019-2023
- Progyny net cash 2019-2023
- American Clean Resources Group total assets 2019-2023
- Humacyte, Inc. operating profit 2020-2023
- Pure Harvest Corporate Group net cash 2016-2020
- Protokinetix net cash 2019-2023
- Harmony Biosciences Holdings gross profit 2019-2023
- Pulmatrix, Inc. net income 2017-2019
- Protagonist Therapeutics net income 2019-2023
- Progyny gross profit 2019-2023
- Insmed gross profit 2017-2019
- Galectin Therapeutics Inc operating profit 2019-2023
- Imago Biosciences, Inc. operating profit 2020-2021
- Galectin Therapeutics Inc net cash 2019-2023
- Prophase Labs gross profit 2019-2023
- Ikena Oncology operating profit 2020-2023
- Integrated Biopharma Inc gross profit 2020-2024
- Q Biomed revenue 2020-2022
- Immuneering gross profit 2020-2023
- Impel Pharmaceuticals gross profit 2021-2022
- Ideaya Biosciences operating profit 2019-2023
- Igc Pharma, Inc. gross profit 2019-2023
- Infinity Pharmaceuticals revenue 2018-2022
- Insmed revenue 2019-2023
- Integrated Biopharma Inc revenue 2020-2024
- Pulmatrix, Inc. revenue 2019-2023
- Immuneering revenue 2020-2023
- Impel Pharmaceuticals revenue 2021-2022
- Igc Pharma, Inc. revenue 2019-2023
- Ikena Oncology revenue 2020-2023
- Igm Biosciences operating profit 2019-2023
- Igc Pharma, Inc. operating profit 2019-2023
- Guardant Health total equity 2019-2023